Top 10 Supplement Registration Mistakes in UAE

Avoid the top supplement registration mistakes in UAE involving classification, claims, labels, testing, documents, applicants, and authority routes.

7/20/202610 min read

Supplement registration mistakes in UAE shown with supplement bottles, tablets, approval documents.
Supplement registration mistakes in UAE shown with supplement bottles, tablets, approval documents.

Top 10 Supplement Registration Mistakes in the UAE: Quick Answer

Author: Product Registration UAE Regulatory Team

Supplement registration mistakes in the UAE usually begin before an application is submitted.

A product may be delayed because it was classified incorrectly, assigned to the wrong regulatory route, supported by inconsistent documents, presented with non-compliant claims, or submitted before its formula and label were fully reviewed.

The ten mistakes brands should avoid are:

  1. Skipping formal product classification

  2. Assuming every supplement follows the same authority pathway

  3. Reviewing ingredients only after the formula is finalized

  4. Submitting inconsistent or incomplete documents

  5. Using medicinal or unsupported claims

  6. Finalizing non-compliant product artwork

  7. Providing an unsuitable testing package

  8. Declaring shelf life without adequate support

  9. Using the wrong applicant, importer, or establishment structure

  10. Changing the product during or after registration without review

Preventing these issues requires more than completing an online form. The formula, label, claims, applicant, manufacturer, technical documents, and intended sales route must describe the same product.

Why Supplement Classification Must Come First

The first question is not simply, “How do we register this supplement?”

The correct first question is:

How will UAE authorities classify this product based on its composition, presentation, claims, intended use, and dosage form?

A product marketed internationally as a dietary supplement may be treated differently in the UAE if it contains pharmacologically active ingredients, medicinal botanicals, unusual dosage levels, disease-related claims, or a presentation associated with pharmaceutical use.

Depending on its characteristics, the product may fall under:

  • Dubai Municipality’s health supplement route through Montaji

  • An Emirates Drug Establishment pathway for pharmaceutical products intended for general sale

  • A natural-source pharmaceutical product pathway

  • A food or functional-food registration route

  • Another specialist regulatory category

The Emirates Drug Establishment now manages federal services relating to medical and pharmaceutical product marketing authorization. Older documents and webpages may still refer to MOHAP because these services were previously managed through the Ministry of Health and Prevention.

Using an outdated authority map can cause companies to prepare the wrong dossier or approach a portal that does not match the current classification.

Mistake 1: Submitting Without Confirming Product Classification

Classification determines almost every later step, including:

  • The responsible authority

  • The eligible applicant

  • The required licence

  • The technical dossier format

  • Ingredient restrictions

  • Testing requirements

  • Permissible claims

  • Label content

  • Registration and post-approval obligations

Companies often rely on how the product is classified in the United States, European Union, United Kingdom, or its country of manufacture.

That classification is useful background information, but it does not automatically determine the UAE route.

A capsule described abroad as a food supplement may require a different assessment in the UAE because of its active ingredients, concentrations, intended purpose, or promotional wording.

How to Avoid This Mistake

Complete a classification assessment before:

  • Ordering UAE-specific testing

  • Legalizing documents

  • Finalizing Arabic artwork

  • Appointing the filing entity

  • Importing commercial quantities

  • Launching advertisements

  • Creating marketplace listings

The classification review should cover the entire commercial presentation, not only the ingredient list.

Mistake 2: Assuming All Supplements Use the Same Registration Route

“Supplement” is a broad commercial term.

It may describe vitamins, minerals, amino acids, botanical extracts, probiotics, sports-nutrition products, general-sale healthcare products, herbal preparations, or products positioned close to medicines.

These categories do not necessarily follow one uniform registration pathway.

Dubai Municipality and Montaji

Health supplements intended for the Dubai market may require registration through Dubai Municipality’s Montaji system.

The assessment can examine the product’s safety, formula, label, claims, supporting documents, manufacturing controls, and laboratory evidence.

Emirates Drug Establishment

A product may instead require federal assessment by the Emirates Drug Establishment when its classification places it within a regulated medical or pharmaceutical category.

This can include certain pharmaceutical products intended for general sale and products derived from natural sources.

Food Registration Routes

A product represented as a conventional food, beverage, functional food, meal component, or fortified food may require assessment through the relevant food-registration route rather than a health supplement pathway.

How to Avoid This Mistake

Do not select the authority based only on the product format.

A powder, drink, gummy, capsule, sachet, liquid, or tablet can be classified differently depending on:

  • Composition

  • Dosage

  • Target consumer

  • Instructions for use

  • Intended purpose

  • Claims

  • Product name

  • Packaging design

Mistake 3: Finalizing the Formula Before Checking UAE Ingredient Rules

An ingredient that is accepted in another market may be restricted, limited, unsuitable, or prohibited in a UAE supplement.

Ingredient review must cover more than whether an ingredient appears on a general permitted list.

Authorities may consider:

  • Maximum daily intake

  • Concentration per serving

  • Ingredient source

  • Botanical species

  • Plant part used

  • Extraction method

  • Combination with other active ingredients

  • Safety for the intended population

  • Pharmaceutical activity

  • Animal-derived materials

  • Contaminant risks

  • Controlled or prohibited substances

For botanical ingredients, the scientific name and plant part should be identified clearly. For amino-acid products, additional composition information may be required.

Why Formula Screening Matters

A formula problem discovered after artwork, manufacturing, testing, and legalization have been completed can force the company to:

  • Reformulate the product

  • Repeat laboratory testing

  • Revise the ingredient report

  • Produce new labels

  • Obtain updated certificates

  • Restart parts of the registration process

How to Avoid This Mistake

Conduct an ingredient-by-ingredient assessment before approving the UAE commercial formula.

The review should compare the formulation certificate, supplement facts, dosage instructions, product specifications, laboratory reports, and label declarations.

Mistake 4: Submitting Documents That Do Not Describe the Same Product

A technically complete dossier can still fail review when its documents contradict one another.

Common inconsistencies include:

  • Different product names across certificates

  • Different ingredient quantities on the formula and label

  • A manufacturer address that does not match the GMP certificate

  • An outdated Certificate of Free Sale

  • Laboratory reports issued for another flavour or formulation

  • Different dosage instructions across documents

  • A label that includes claims absent from the technical file

  • A barcode associated with another product

  • An analysis report that does not match current specifications

Documents Commonly Reviewed

Depending on the classification and pathway, the dossier may include:

  • Certificate of Free Sale

  • Detailed ingredient or formulation report

  • Physical, chemical, and microbiological analysis report

  • Good Manufacturing Practice certificate

  • Accredited laboratory test report

  • Product specifications

  • Finished product artwork

  • Manufacturing authorization

  • Applicant or agency authorization

  • Halal documentation for relevant animal-derived ingredients

  • Organic certification where an organic claim is made

  • Safety assessments or scientific evidence for specific ingredients

  • Claim-support documentation

Not every product requires exactly the same set of documents. However, every submitted document should identify the same formulation, manufacturer, product name, dosage form, and commercial presentation.

How to Avoid This Mistake

Create a dossier consistency matrix before submission.

Compare every critical field across the:

  • Formula

  • Free-sale documentation

  • GMP certificate

  • Analysis certificate

  • Laboratory reports

  • Artwork

  • Application form

  • Product specifications

Mistake 5: Using Medicinal, Disease-Related, or Unsupported Claims

Claims can change both the acceptability and classification of a supplement.

Health supplements should not be promoted as products that diagnose, prevent, treat, or cure diseases.

Risky claims include wording that directly or indirectly suggests that the product:

  • Treats diabetes

  • Prevents cancer

  • Cures arthritis

  • Reverses fatty liver

  • Treats depression

  • Prevents infection

  • Replaces prescribed medication

  • Corrects hormonal disorders

  • Produces guaranteed weight loss

  • Eliminates a medical condition

The problem is not limited to the front label.

Authorities may consider claims appearing on:

  • Packaging

  • Leaflets

  • Websites

  • Social media

  • Influencer content

  • Advertisements

  • Marketplace listings

  • Distributor brochures

  • Before-and-after images

Are All Health Claims Prohibited?

No.

Appropriate nutritional, health-support, or structure-function claims may be acceptable when they match the product’s classification and are supported by suitable scientific evidence.

The difference between “supports normal immune function” and “prevents viral infection” is regulatory, not merely stylistic.

How to Avoid This Mistake

Review each claim for:

  • Regulatory classification impact

  • Scientific substantiation

  • Ingredient relevance

  • Dose relevance

  • Arabic and English consistency

  • Implied medicinal meaning

  • Use of absolute or guaranteed language

Do not assume that a claim accepted in another country will automatically be approved in the UAE.

Mistake 6: Treating Label Review as a Translation Task

A compliant supplement label is not created by translating the foreign artwork into Arabic.

The UAE artwork must align with the approved formula, product classification, safety information, dosage, claims, and technical dossier.

Depending on the pathway, required label elements may include:

  • Brand name

  • Clear product name

  • Manufacturer or responsible-agent details

  • Country of origin

  • Active and inactive ingredients

  • Pack size

  • Production and expiry dates

  • Storage conditions

  • Recommended dosage

  • Directions for use

  • Intended purpose

  • Health or safety warnings

  • Unique product barcode

  • Batch or lot number

  • Supplement facts panel

  • Vitamin and mineral quantities

  • Percentage daily values where applicable

Frequent Artwork Problems

Common label mistakes include:

  • Product name does not explain what the product is

  • Dosage differs from the application

  • Product claims exceed the supporting evidence

  • Mandatory warnings are missing

  • Country-of-origin wording is unclear

  • Ingredient names are incomplete

  • Botanical ingredients lack scientific identification

  • Barcode is duplicated or unreadable

  • Production or expiry information is removable or unclear

  • Imported stickers cover essential information

  • Arabic wording creates a stronger claim than the English text

How to Avoid This Mistake

Complete regulatory artwork validation before printing commercial packaging.

The reviewed artwork should be the same version used for registration, manufacturing, import, ecommerce listings, and promotional materials.

Mistake 7: Using the Wrong Laboratory Tests or Test Reports

Laboratory testing should follow the product category, formulation, risks, and authority requirements.

A generic Certificate of Analysis may not satisfy the required assessment when the authority expects evidence relating to specific safety or quality parameters.

Testing can involve:

  • Physical characteristics

  • Chemical specifications

  • Microbiological quality

  • Heavy metals

  • Ingredient identity

  • Active-ingredient quantities

  • Restricted substances

  • Prohibited pharmaceutical adulterants

  • Alcohol content where relevant

  • Animal-derived material risks

  • Product-specific contaminants

The exact tests may be confirmed during product assessment.

Why Reports Are Rejected or Questioned

A laboratory report may be unsuitable when:

  • The tested product name does not match the application

  • The batch cannot be traced

  • The method is not identified

  • Required parameters are missing

  • The report belongs to a previous formulation

  • The laboratory status is unsuitable

  • The result cannot be linked to the submitted product

  • The report is expired or no longer representative

How to Avoid This Mistake

Confirm the classification and expected test scope before sending samples to a laboratory.

Testing should support the actual UAE formula and final commercial product.

Mistake 8: Declaring Shelf Life Without Adequate Technical Support

A printed expiry date is not sufficient evidence that a supplement will remain safe and compliant throughout its declared shelf life.

The product should maintain acceptable:

  • Ingredient levels

  • Microbiological quality

  • Physical characteristics

  • Packaging integrity

  • Safety profile

  • Performance under stated storage conditions

Products containing sensitive vitamins, probiotics, oils, botanicals, enzymes, or moisture-sensitive ingredients may require particular attention.

Does Every Product Need the Same Stability Package?

No.

The evidence required depends on the product, formulation, packaging, storage conditions, shelf-life claim, and authority pathway.

Authorities may request additional data when the declared shelf life is not adequately supported or when the formulation presents stability concerns.

How to Avoid This Mistake

Ensure that the declared shelf life is supported by appropriate product data and that the label reflects the correct storage conditions.

Do not copy the expiry period from a different flavour, pack format, formulation, or climate zone without technical justification.

Mistake 9: Using the Wrong Applicant or Establishment Structure

A foreign manufacturer may not be able to complete every UAE registration route directly.

The eligible applicant depends on the authority and classification.

For a Dubai Municipality health supplement registration, the applicant generally needs an appropriately licensed UAE business structure that satisfies the relevant activity and establishment requirements.

For federal pharmaceutical registration through the Emirates Drug Establishment, the route may require a licensed medical warehouse, registered marketing authorization holder, approved manufacturer, or another eligible establishment.

Why This Causes Delays

A strong product dossier cannot correct an ineligible applicant structure.

Problems can arise when:

  • The trade licence lacks the required activity

  • The applicant does not hold the required establishment approval

  • The manufacturer is not registered where required

  • The authorization letter names the wrong entity

  • The importer, distributor, and registration holder roles are unclear

  • The portal account belongs to an entity that cannot legally submit the application

How to Avoid This Mistake

Confirm the applicant model before legalizing documents or signing a distributor agreement.

The company should understand who will:

  • Own or control the registration

  • Submit the application

  • Import the product

  • Respond to authority questions

  • Maintain the dossier

  • Manage renewals and variations

  • Handle recalls or market actions

Mistake 10: Changing the Product During or After Registration Without Review

Registration applies to a defined product file.

Changes made during review can create new inconsistencies, while changes made after approval may require notification, amendment, or a new assessment.

Potentially significant changes include:

  • Product name

  • Brand

  • Formula

  • Ingredient source

  • Active-ingredient concentration

  • Manufacturer

  • Manufacturing site

  • Applicant or agent

  • Dosage instructions

  • Claims

  • Warnings

  • Packaging

  • Pack size

  • Shelf life

  • Barcode

  • Artwork

Why Version Control Matters

Without version control, the authority may review one formula while the factory manufactures another and the distributor markets a third label.

That creates compliance risks during:

  • Import inspection

  • Market surveillance

  • Product sampling

  • Ecommerce review

  • Renewal

  • Complaint investigation

  • Recall management

How to Avoid This Mistake

Freeze the submission version before filing and record every approved component.

Any proposed change should be assessed for regulatory impact before it is implemented.

What Is the Safest UAE Supplement Registration Workflow?

A controlled supplement-registration project should follow this sequence:

1. Define the Product

Collect the complete formula, dosage form, intended use, daily intake, target users, claims, packaging, and manufacturing details.

2. Confirm the Classification

Determine whether the product follows a Dubai Municipality, Emirates Drug Establishment, food-registration, or another authority route.

3. Confirm the Applicant

Verify that the filing entity, importer, registration holder, manufacturer, and warehouse structure satisfy the selected pathway.

4. Screen the Formula

Review ingredients, quantities, botanical identities, daily intake, animal-derived materials, prohibited substances, and category limits.

5. Map the Required Evidence

Identify the certificates, reports, authorizations, testing, safety data, claim support, and manufacturing documents required for the product.

6. Review Claims and Artwork

Ensure that the label, website language, advertisements, and marketplace descriptions remain within the permitted product positioning.

7. Check Dossier Consistency

Confirm that every document describes the same product version.

8. Submit Through the Correct Route

File only after the formula, applicant, label, and supporting evidence are ready.

9. Manage Authority Questions Carefully

Responses should be accurate, complete, and consistent with the submitted dossier.

10. Control the Approved Product

Maintain the registration, assess changes, monitor claims, and ensure that the marketed product continues to match the approved file.

What Usually Causes Supplement Registration Delays?

The most common causes are not a lack of documents alone.

Delays usually arise from:

  • Incorrect classification

  • Wrong authority selection

  • Ineligible applicant structure

  • Restricted ingredients

  • Unsupported claims

  • Formula and label mismatches

  • Unsuitable laboratory reports

  • Outdated certificates

  • Uncontrolled artwork changes

  • Incomplete responses to authority questions

A complete submission is not necessarily a compliant submission. The documents must also be accurate, current, route-specific, and internally consistent.

How Product Registration UAE Helps Reduce Approval Risk

Product Registration UAE supports manufacturers, importers, distributors, and private-label brands with:

  • Product classification

  • Authority-pathway assessment

  • Formula and ingredient screening

  • Applicant and licence review

  • Technical dossier gap analysis

  • Certificate and report verification

  • Label and artwork validation

  • Arabic compliance review

  • Health-claim assessment

  • Testing-document coordination

  • Submission preparation

  • Authority-response support

  • Registration variation and renewal planning

The objective is to identify regulatory gaps before they become authority questions, rejected artwork, repeated testing, or delayed market entry.

Frequently Asked Questions

  • Are Supplements Still Registered Through MOHAP in the UAE?

Federal medical and pharmaceutical product services have been transferred to the Emirates Drug Establishment. Older material may still use MOHAP terminology, but companies should confirm the active EDE service and current submission route.

Dubai Municipality continues to regulate health supplements registered for the Dubai market through Montaji.

  • Does Every Supplement Need Montaji Registration?

No single route applies to every product.

Montaji is relevant to health supplements falling under Dubai Municipality’s consumer-product framework. Products classified as pharmaceutical products, natural-source medical products, conventional foods, or other regulated categories may follow different routes.

  • Can a Supplement Make an Immunity Claim?

A carefully worded structure-function or health-support claim may be acceptable when it is appropriate for the product and scientifically substantiated.

Claims that suggest the product prevents, treats, or cures an infection or disease are different and can be prohibited.

  • Is a Certificate of Free Sale Always Required?

A valid Certificate of Free Sale is a core document for the Dubai Municipality health supplement dossier and may also be required under other routes.

The issuer, legalization, validity, and product-name consistency should be checked against the selected pathway.

  • Is Arabic Mandatory on Supplement Labels?

Language requirements depend on the classification and authority route. Required information should be provided in the accepted language format, with Arabic content reviewed where applicable.

Adding Arabic without regulatory review can still create problems if the translation changes the meaning of the English claims or instructions.

  • Does Every Supplement Need Stability Testing?

Not every product receives an identical stability requirement.

However, the product should have adequate stability, an appropriate shelf life, suitable packaging, and storage conditions supported by relevant technical evidence. Additional information may be requested during assessment.

  • Can One Registration Cover Several Flavours or Variants?

This depends on the differences between the variants and the scope accepted by the authority.

Changes to active ingredients, concentrations, claims, dosage, manufacturing, or product identity may prevent variants from being handled under one registration.

  • Can a Foreign Brand Register Without a UAE Company?

The filing route normally requires an eligible UAE entity, such as an appropriately licensed applicant, warehouse, agent, importer, or marketing authorization holder.

The exact structure depends on the product classification and responsible authority.

Prepare the Product Before Preparing the Application

Successful supplement registration begins with product readiness, not portal access.

Brands that confirm the classification, screen the formula, control their claims, validate the artwork, and align the technical dossier before filing are better positioned to avoid preventable review cycles.

Contact us or use the chatbot to review your supplement’s classification, formula, claims, label, applicant structure, and registration file before submission.

Continue Reading

Explore Further: Read Related Articles